Independent register of U.S. FDA drug recalls · updated Oct 13, 2026
RxRecalls Get alerts

Class II drug recalls - moderate risk

Class II means the product may cause temporary or medically reversible harm, and serious harm is unlikely. It is by far the largest recall class - most potency, dissolution and labeling problems land here.

14,543 recalls, newest first.

Class II · Moderate risk

Formula 9

Lack of Assurance of Sterility: incomplete or missing data regarding production.

Terminated Sterility / contamination Meditech Laboratories, Inc D-0804-2016
Class II · Moderate risk

Mannitol I.V.

Chemical Contamination: Potential for contamination of the products with an aromatic hydrocarbon resin.

Terminated Chemical / undeclared Hospira Inc. D-0831-2016
Class II · Moderate risk

Aminosyn-PF

Chemical Contamination: Potential for contamination of the products with an aromatic hydrocarbon resin.

Terminated Chemical / undeclared Hospira Inc. D-0830-2016
Class II · Moderate risk

Dextrose Injection

Chemical Contamination: Potential for contamination of the products with an aromatic hydrocarbon resin.

Terminated Chemical / undeclared Hospira Inc. NDC 0409-7935-19 D-0829-2016
Class II · Moderate risk

Dextrose Injection

Chemical Contamination: Potential for contamination of the products with an aromatic hydrocarbon resin.

Terminated Chemical / undeclared Hospira Inc. NDC 0409-7936-19 D-0828-2016
Class II · Moderate risk

Dextrose Injection

Chemical Contamination: Potential for contamination of the products with an aromatic hydrocarbon resin.

Terminated Chemical / undeclared Hospira Inc. NDC 0409-7918-19 D-0827-2016
Class II · Moderate risk

Zoledronic Acid Injection

Lack of Assurance of Sterility; defective seals where the metal silver ring was not attached tightly to the vial

Terminated Sterility / contamination Dr. Reddy's Laboratories, Inc. NDC 55111-688-52 D-0784-2016
Class II · Moderate risk

Fluconazole Injection

Cross contamination with other products: metronidazole

Terminated Cross-contamination Sagent Pharmaceuticals Inc NDC 25021-0113-82 D-0780-2016

Recalls by year